Abstract
Food allergy significantly impacts health-related quality of life (HRQL) of patients and their families. Treatments that can induce clinical remission are expected to improve HRQL. The Probiotic Peanut Oral ImmunoTherapy (PPOIT-003) multi-center randomized trial evaluated the impact of a novel peanut allergy treatment on HRQL out to 12-months post-treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
